A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19 by Kota Iwahori, Takuro Nii, Norihiko Yamaguchi, Takahiro Kawasaki, Satomi Okamura, Kazuki Hashimoto, Takanori Matsuki, Kazuyuki Tsujino, Keisuke Miki, Akio Osa, Sho Goya, Kinya Abe, Masahide Mori, Yoshito Takeda, Tomomi Yamada, Hiroshi Kida, Atsushi Kumanogoh

Get full text